270 related articles for article (PubMed ID: 20733034)
1. DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomas.
Lai AY; Fatemi M; Dhasarathy A; Malone C; Sobol SE; Geigerman C; Jaye DL; Mav D; Shah R; Li L; Wade PA
J Exp Med; 2010 Aug; 207(9):1939-50. PubMed ID: 20733034
[TBL] [Abstract][Full Text] [Related]
2. Novel CTCF binding at a site in exon1A of BCL6 is associated with active histone marks and a transcriptionally active locus.
Batlle-López A; Cortiguera MG; Rosa-Garrido M; Blanco R; del Cerro E; Torrano V; Wagner SD; Delgado MD
Oncogene; 2015 Jan; 34(2):246-56. PubMed ID: 24362533
[TBL] [Abstract][Full Text] [Related]
3. BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms.
Parekh S; Polo JM; Shaknovich R; Juszczynski P; Lev P; Ranuncolo SM; Yin Y; Klein U; Cattoretti G; Dalla Favera R; Shipp MA; Melnick A
Blood; 2007 Sep; 110(6):2067-74. PubMed ID: 17545502
[TBL] [Abstract][Full Text] [Related]
4. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
Phan RT; Dalla-Favera R
Nature; 2004 Dec; 432(7017):635-9. PubMed ID: 15577913
[TBL] [Abstract][Full Text] [Related]
5. Role of CTCF protein in regulating FMR1 locus transcription.
Lanni S; Goracci M; Borrelli L; Mancano G; Chiurazzi P; Moscato U; Ferrè F; Helmer-Citterich M; Tabolacci E; Neri G
PLoS Genet; 2013; 9(7):e1003601. PubMed ID: 23874213
[TBL] [Abstract][Full Text] [Related]
6. LITAF, a BCL6 target gene, regulates autophagy in mature B-cell lymphomas.
Bertolo C; Roa S; Sagardoy A; Mena-Varas M; Robles EF; Martinez-Ferrandis JI; Sagaert X; Tousseyn T; Orta A; Lossos IS; Amar S; Natkunam Y; Briones J; Melnick A; Malumbres R; Martinez-Climent JA
Br J Haematol; 2013 Sep; 162(5):621-30. PubMed ID: 23795761
[TBL] [Abstract][Full Text] [Related]
7. Breaking bad in the germinal center: how deregulation of BCL6 contributes to lymphomagenesis.
Hatzi K; Melnick A
Trends Mol Med; 2014 Jun; 20(6):343-52. PubMed ID: 24698494
[TBL] [Abstract][Full Text] [Related]
8. GFI1B, EVI5, MYB--additional genes that cooperate with the human BCL6 gene to promote the development of lymphomas.
Baron BW; Anastasi J; Bies J; Reddy PL; Joseph L; Thirman MJ; Wroblewski K; Wolff L; Baron JM
Blood Cells Mol Dis; 2014 Jan; 52(1):68-75. PubMed ID: 23910958
[TBL] [Abstract][Full Text] [Related]
9. BCL6 promoter interacts with far upstream sequences with greatly enhanced activating histone modifications in germinal center B cells.
Ramachandrareddy H; Bouska A; Shen Y; Ji M; Rizzino A; Chan WC; McKeithan TW
Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11930-5. PubMed ID: 20547840
[TBL] [Abstract][Full Text] [Related]
10. The ITM2B (BRI2) gene is a target of BCL6 repression: Implications for lymphomas and neurodegenerative diseases.
Baron BW; Baron RM; Baron JM
Biochim Biophys Acta; 2015 May; 1852(5):742-8. PubMed ID: 25557390
[TBL] [Abstract][Full Text] [Related]
11. Identification of negative regulatory regions within the first exon and intron of the BCL6 gene.
Kikuchi M; Miki T; Kumagai T; Fukuda T; Kamiyama R; Miyasaka N; Hirosawa S
Oncogene; 2000 Oct; 19(42):4941-5. PubMed ID: 11039912
[TBL] [Abstract][Full Text] [Related]
12. STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas.
Walker SR; Nelson EA; Frank DA
Oncogene; 2007 Jan; 26(2):224-33. PubMed ID: 16819511
[TBL] [Abstract][Full Text] [Related]
13. POZ-, AT-hook-, and zinc finger-containing protein (PATZ) interacts with human oncogene B cell lymphoma 6 (BCL6) and is required for its negative autoregulation.
Pero R; Palmieri D; Angrisano T; Valentino T; Federico A; Franco R; Lembo F; Klein-Szanto AJ; Del Vecchio L; Montanaro D; Keller S; Arra C; Papadopoulou V; Wagner SD; Croce CM; Fusco A; Chiariotti L; Fedele M
J Biol Chem; 2012 May; 287(22):18308-17. PubMed ID: 22493480
[TBL] [Abstract][Full Text] [Related]
14. Acetylation inactivates the transcriptional repressor BCL6.
Bereshchenko OR; Gu W; Dalla-Favera R
Nat Genet; 2002 Dec; 32(4):606-13. PubMed ID: 12402037
[TBL] [Abstract][Full Text] [Related]
15. The BCL6 proto-oncogene: a leading role during germinal center development and lymphomagenesis.
Jardin F; Ruminy P; Bastard C; Tilly H
Pathol Biol (Paris); 2007 Feb; 55(1):73-83. PubMed ID: 16815642
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of the human retinoblastoma tumor suppressor gene promoter by CTCF.
De La Rosa-Velázquez IA; Rincón-Arano H; Benítez-Bribiesca L; Recillas-Targa F
Cancer Res; 2007 Mar; 67(6):2577-85. PubMed ID: 17363576
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of action of BCL6 during germinal center B cell development.
Huang C; Melnick A
Sci China Life Sci; 2015 Dec; 58(12):1226-32. PubMed ID: 26566802
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic repression of RARRES1 is mediated by methylation of a proximal promoter and a loss of CTCF binding.
Peng Z; Shen R; Li YW; Teng KY; Shapiro CL; Lin HJ
PLoS One; 2012; 7(5):e36891. PubMed ID: 22615834
[TBL] [Abstract][Full Text] [Related]
19. The BCL6 gene in B-cell lymphomas with 3q27 translocations is expressed mainly from the rearranged allele irrespective of the partner gene.
Lossos IS; Akasaka T; Martinez-Climent JA; Siebert R; Levy R
Leukemia; 2003 Jul; 17(7):1390-7. PubMed ID: 12835729
[TBL] [Abstract][Full Text] [Related]
20. AID assists DNMT1 to attenuate BCL6 expression through DNA methylation in diffuse large B-cell lymphoma cell lines.
Jiao J; Lv Z; Zhang P; Wang Y; Yuan M; Yu X; Otieno Odhiambo W; Zheng M; Zhang H; Ma Y; Ji Y
Neoplasia; 2020 Mar; 22(3):142-153. PubMed ID: 32062068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]